Dr Reddy's Laboratories consolidated net profit declines 82.59% in the March 2022 quarter

Sales rise 14.98% to Rs 5436.80 crore

Net profit of Dr Reddy's Laboratories declined 82.59% to Rs 97.00 crore in the quarter ended March 2022 as against Rs 557.30 crore during the previous quarter ended March 2021. Sales rose 14.98% to Rs 5436.80 crore in the quarter ended March 2022 as against Rs 4728.40 crore during the previous quarter ended March 2021.

For the full year,net profit rose 11.83% to Rs 2182.50 crore in the year ended March 2022 as against Rs 1951.60 crore during the previous year ended March 2021. Sales rose 13.00% to Rs 21439.10 crore in the year ended March 2022 as against Rs 18972.20 crore during the previous year ended March 2021.

ParticularsQuarter EndedYear EndedMar. 2022Mar. 2021% Var.Mar. 2022Mar. 2021% Var.Sales5436.804728.40 15 21439.1018972.20 13 OPM %8.3022.27 -17.5720.40 - PBDT551.901124.00 -51 4226.604112.30 3 PBT258.90815.20 -68 3061.402883.50 6 NP97.00557.30 -83 2182.501951.60 12

Powered by Capital Market - Live News